EE531 Cost-Utility Analysis of Once-Weekly Semaglutide Versus Dulaglutide in Patients With Type 2 Diabetes Requiring Treatment With a GLP-1 Receptor Agonist
作者
J Garcia Uranga,S Jung,SMEAT Dahaoui
出处
期刊:Value in Health [Elsevier BV] 日期:2022-12-01卷期号:25 (12): S160-S160被引量:1